Adalimumab


( Last Updated : February 4, 2013)
Generic Name:
Adalimumab
Project Status:
Complete
Therapeutic Area:
Arthritis, juvenile idiopathic
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0308-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Arthritis, Juvenile Idiopathic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: